Call: +7 771 977 66 65, +7 705 421 2277
Sign in or Register
My basket

Astana Biomed Group, an authorized Abcam distributor in Central Asia

Abiomed homepage

  • Categories
    Signal Transduction
    Cancer
    Epigenetics and Nuclear Signaling
    Immunology
    Cell Biology
    Cardiovascular
    Neuroscience
    Tags & Cell Markers
    Kits/ Lysates/ Other
    Developmental Biology
    Microbiology
    Biochemicals
    Secondary antibodies
    Isotype/Loading Controls
    Antibody Arrays
  • About us
  • Partners
  • Contact
    Address

    Saryarka 32, 18, 010000, Astana city, Kazakhstan

    Telephone +7 771 977 66 65, +7 705 421 2277

    Email

    laboratory@ctlab.kz, orders@abiomed.kz

Back to category
Neuroscience Neurology process Neurodegenerative disease Huntington's disease

Human UBE2K (HIP2/LIG) knockout HCT116 cell lysate (ab257779)

Human UBE2K (HIP2/LIG) knockout HCT116 cell lysate (ab257779)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)

You may also be interested in

Product image
Anti-COQ10B antibody (ab41997)
Product image
Anti-DNAJB6 antibody [EPR17122] - BSA and Azide free (ab240346)
Product image
Recombinant Human Huntingtin protein (Tagged) (ab112300)
Product image
Anti-GAPDH antibody - Loading Control (ab9485)

Properties

  • Storage instructions

    Store at -80°C. Please refer to protocols.
  • Components 1 kit
    ab263589 - Human UBE2K knockout HCT116 cell lysate 1 x 100µg
    ab255555 - Human wild-type HCT116 cell lysate 1 x 100µg
  • Research areas

    • Neuroscience
    • Neurology process
    • Neurodegenerative disease
    • Huntington's disease
    • Epigenetics and Nuclear Signaling
    • Ubiquitin & Ubiquitin Like Modifiers
    • E2 Ubiquitin Conjugating Enzymes
    • Cell Biology
    • Proteolysis / Ubiquitin
    • Proteasome / Ubiquitin
    • Ubiquitin E2 Enzymes
  • Cell type

    epithelial
  • Disease

    Carcinoma
  • STR Analysis

    Amelogenin X D5S818: 10, 11 D13S317: 10, 12 D7S820: 11, 12 D16S539: 11, 13 vWA: 17, 22 TH01: 8,9 TPOX: 8, 9 CSF1PO: 7, 10

Images

  • Western blot - Human UBE2K (HIP2/LIG) knockout HCT116 cell lysate (ab257779)
    Western blot - Human UBE2K (HIP2/LIG) knockout HCT116 cell lysate (ab257779)

    Lane 1:Wild-type HCT116 cell lysate (20 ug)
    Lane 2:UBE2K knockout HCT116 cell lysate (20 ug)
    Lane 3:Daudi cell lysate (20 ug)
    Lane 4:Jurkat cell lysate (20 ug)

    ab52930 was shown to specifically react with HIP2/LIG in wild-type HCT116 cells. Loss of signal was observed when knockout cell line ab266899 (knockout cell lysate ab257779) was used. Wild-type and HIP2/LIG knockout samples were subjected to SDS-PAGE. ab52930 and Anti-GAPDH antibody [6C5] - Loading Control (ab8245) were incubated overnight at 4oC at 1 in 1000 dilution and 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.

  • Sanger Sequencing - Human UBE2K knockout HCT116 cell lysate (ab257779)
    Sanger Sequencing - Human UBE2K knockout HCT116 cell lysate (ab257779)
    Homozygous: Insertion of the selection cassette in exon1

Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES"
For licensing inquiries, please contact partnerships@abcam.com

Clear all

Recently viewed products

  •  
  • Product image

    Anti-FOXA2 antibody [EPR4466] (ab108422)

  •  
  • Product image

    Anti-COPS3/CSN3 antibody [EPR3127] (ab79698)

  •  
  • Product image

    Anti-LAMP1 antibody [1D4B] (ab25245)

  •  
  • Product image

    Anti-FOXB2 antibody [EPR11476] (ab170897)

  •  
  • Product image

    Anti-CD11b antibody [ITGAM/3338] (ab269676)

  •  
  • Product image

    Human Fibrinogen Matched Antibody Pair Kit (ab246840)

Get resources and offers direct to your inbox Sign up
© 2021 Astana Biomed Group LLP. All rights reserved.